Microbial metabolite indole-3-propionic acid drives mitochondrial respiration in CD4+ T cells to confer protection

Qing Li1,2, Rodrigo de Oliveira Formiga1,2, Virginie Puchois1,2

  • 1Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France.

Nature Metabolism
|October 21, 2025
PubMed

Insights

Indole-3-propionic acid (IPA) enhances T cell mitochondrial respiration by boosting fatty acid and amino acid oxidation. This metabolite also reduces inflammation by reprogramming T cell metabolism.

Area of Science:

  • Immunology
  • Metabolic studies
  • Microbiome research

Background:

  • Gut microbiota metabolites significantly influence immune cell function and metabolism.
  • Identifying specific metabolites that modulate T cell mitochondrial activity is crucial for understanding immune regulation.

Purpose of the Study:

  • To screen gut microbiota metabolites for their effects on T cell mitochondrial metabolism.
  • To investigate the impact of indole-3-propionic acid (IPA) on CD4+ T cell function and metabolism.

Main Methods:

  • Screening of gut microbiota metabolites for modulators of mitochondrial metabolism in T cells.
  • Analysis of IPA's effects on CD4+ T cell respiration, substrate oxidation (fatty acid oxidation [FAO] and amino acid oxidation [AAO]), and glycolytic capacity.
  • Investigating the role of peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ) in mediating IPA's effects.
  • In vivo studies using mice with gut bacteria depletion or colitis to assess IPA's therapeutic potential.

Main Results:

  • Indole-3-propionic acid (IPA) stimulates mitochondrial respiration in CD4+ T cells by increasing fatty acid oxidation (FAO) and amino acid oxidation (AAO), while decreasing glycolysis.
  • IPA inhibits the differentiation of CD4+ T cells into type 1 and type 17 helper T cell phenotypes.
  • The metabolic and immune effects of IPA are mediated through peroxisome proliferator-activated receptor-β/δ (PPAR-β/δ).
  • IPA administration in mice with gut bacteria depletion or colitis restores mitochondrial respiration in colonic CD4+ T cells by enhancing FAO and AAO, thereby reducing inflammation.

Conclusions:

  • The anti-inflammatory effects of IPA are achieved through the metabolic reprogramming of CD4+ T cells, enhancing their mitochondrial respiration.
  • IPA represents a potential therapeutic agent for inflammatory conditions by modulating T cell metabolism and function.